Analabs Resources Bhd's Days Sales Outstanding for the
three
months ended in Apr. 2026 was 27.28.
Analabs Resources Bhd's Days Inventory for the
three
months ended in Apr. 2026 was 62.56.
Analabs Resources Bhd's Days Payable for the
three
months ended in Apr. 2026 was 48.93.
Therefore, Analabs Resources Bhd's Cash Conversion Cycle (CCC) for the
three
months ended in Apr. 2026 was 40.91.
Analabs Resources Bhd (XKLS:7083) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Analabs Resources Bhd Cash Conversion Cycle Related Terms
Analabs Resources Bhd Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Analabs Resources Bhd's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7083 vs LIN, SHW, ECL: Cash Conversion Cycle Comparison
For the Specialty Chemicals subindustry, Analabs Resources Bhd's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Analabs Resources Bhd Cash Conversion Cycle vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Analabs Resources Bhd's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Analabs Resources Bhd's Cash Conversion Cycle falls into.
Analabs Resources Bhd Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Analabs Resources Bhd's Cash Conversion Cycle for the fiscal year that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Analabs Resources Bhd (XKLS:7083) has a Cash Conversion Cycle of 40.91 as of Apr. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Analabs Resources Bhd and its competitors.
Is Analabs Resources Bhd's Cash Conversion Cycle too high?
Analabs Resources Bhd's current Cash Conversion Cycle is 40.91. The Chemicals industry median Cash Conversion Cycle is 89.14. Analabs Resources Bhd's value of 40.91 is 54.1% below this industry median. Overall, Analabs Resources Bhd has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Analabs Resources Bhd's Cash Conversion Cycle compare to LIN and SHW?
Analabs Resources Bhd's Cash Conversion Cycle of 40.91 can be compared against companies in the Chemicals industry. The industry median Cash Conversion Cycle is 89.14. Analabs Resources Bhd's value of 40.91 is 54.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Chemicals company?
The median Cash Conversion Cycle among Chemicals companies is 89.14, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Analabs Resources Bhd's current Cash Conversion Cycle of 40.91 is 54.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Analabs Resources Bhd and its competitors. For the Chemicals industry, the median Cash Conversion Cycle is 89.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Analabs Resources Bhd's current Cash Conversion Cycle is 40.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Analabs Resources Bhd stock overvalued right now?
Based on GuruFocus' analysis, Analabs Resources Bhd (XKLS:7083) is currently considered Modestly Overvalued. The stock's GF Value™ is RM1.53, compared to a current price of RM1.79 — trading 17% above its estimated fair value. The current Cash Conversion Cycle is 40.91 and 54.1% below the Chemicals industry median of 89.14. Analabs Resources Bhd's overall GF Score™ is 71/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Analabs Resources Bhd (XKLS:7083), the current Cash Conversion Cycle is 40.91 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Analabs Resources Bhd (XKLS:7083) Overvalued in 2026?
Based on GuruFocus' analysis, Analabs Resources Bhd stock appears to be overvalued.
The current stock price of RM1.79 is trading 17% above its estimated GF Value™ of RM1.53.
GuruFocus considers Analabs Resources Bhd to be Modestly Overvalued.
Key valuation signals for XKLS:7083:
Cash Conversion Cycle: 40.91
GF Value™: RM1.53 vs. price of RM1.79 (17% above fair value)
Industry Position: 54.1% below the Chemicals median
No single metric tells the full story. See the XKLS:7083 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Analabs Resources Bhd is a Malaysia-based company engaged in the businesses of investment holding and the provision of management services. It has five business segments, which include: Manufacturing, formulation, and sale of resin, chemicals, and building materials; Recovery and sale of recycled products; Contract work, pipe laying, and rehabilitation; Culture and sale of prawns; Investment holding and property letting, and asset and portfolio management. The company earns the majority of its revenue from the manufacturing, formulation, and sale of resin, chemicals, and building materials. Geographically, the company derives its maximum revenue from Malaysia and the rest from Singapore.
71GF Score
Get the complete analysis for XKLS:7083
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7083 has been successfully added to your 
